|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61F 2/02 | |||
| A61K 31/5575 | |||
| A61L 31/06 | |||
| A61L 31/16 | |||
| A61M 31/00 | |||
| A61F 9/00 |
| (11) | Number of the document | 2750660 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12827871.0 |
| Date of filing the European patent application | 2012-08-29 | |
| (97) | Date of publication of the European application | 2014-07-09 |
| (45) | Date of publication and mention of the grant of the patent | 2016-10-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2012/002210 |
| Date | 2012-08-29 |
| (87) | Number | WO 2013/030679 |
| Date | 2013-03-07 |
| (30) | Number | Date | Country code |
| 201161528736 P | 2011-08-29 | US | |
| 201261644397 P | 2012-05-08 | US |
| (72) |
CADDEN, Suzanne, CA
HAO, Yong, CA
UTKHEDE, Deepank, CA
RUBINCHIK, Valery, CA
KJELLBOTN, Charles Richard, CA
|
| (73) |
Mati Therapeutics Inc.,
4317 Dunning Lane, Austin, TX 78746,
US
|
| (54) | SUSTAINED RELEASE DELIVERY OF ACTIVE AGENTS TO TREAT GLAUCOMA AND OCULAR HYPERTENSION |
| SUSTAINED RELEASE DELIVERY OF ACTIVE AGENTS TO TREAT GLAUCOMA AND OCULAR HYPERTENSION |